Sonnet BioTherapeutics Quote - SONN

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

1.41

Bid

1.45

Ask

1.61

Volume

289,945

1.4201 Day's Range 1.66

1.41 52 Week Range 18.7192

Market Cap

916.941k

Previous Close

1.56

Open

1.59

Last Trade

1.49

Last Trade Time

Financial Volume

US$ 435,047

VWAP

1.5004

Average Volume (3m)

1,381,412

Shares Outstanding

650,313

Dividend Yield

PE Ratio

-0.05

Earnings Per Share (EPS)

-28.96

Revenue

148k

Net Profit

-18.83M

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and... Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others. Show more

Sector

Pharmaceutical Preparations

Industry

Management Consulting Svcs

Website

www.sonnetbio.com

Headquarters

Wilmington, Delaware, USA

Founded

2020

Sonnet BioTherapeutics Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SONN. The last closing price for Sonnet BioTherapeutics was US$1.56. Over the last year, Sonnet BioTherapeutics shares have traded in a share price range of US$ 1.41 to US$ 18.7192.

Sonnet BioTherapeutics currently has 650,313 shares outstanding. The market capitalization of Sonnet BioTherapeutics is US$1.01 million. Sonnet BioTherapeutics has a price to earnings ratio (PE ratio) of -0.05.

Form D - Notice of Exempt Offering of Securities

Sonnet BioTherapeutics Announces Release of the Next CEO Corner Segment

PRINCETON, NJ, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic...

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

Sonnet BioTherapeutics Reports Fiscal Year 2024 Financial Results and Provides Corporate Update

Continued progress with both clinical trials of lead program, SON-1010, for solid tumors and Platinum-Resistant Ovarian Cancer (PROC) Executed licensing agreement to support initiation of a...

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Sonnet BioTherapeutics Announces $3.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

PRINCETON, NJ, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the "Company" or "Sonnet") (NASDAQ:SONN), a clinical-stage company developing targeted immunotherapeutic...

Form 8-K - Current report

Sonnet BioTherapeutics Announces Topline Safety Data Following Successful Completion of SON-1010 Monotherapy Dose Escalation in Phase 1 SB101 Trial

The maximum tolerated dose (MTD) of SON-1010 was set at 1200 ng/kg, without dose-limiting toxicity or evidence of cytokine release syndrome at any dose level Stable disease (SD) at four months...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.42	-22.9508196721	1.83	1.94	1.41	280396	1.6552047	CS
4	-1.7	-54.6623794212	3.11	4.85	1.41	2898490	1.97529536	CS
12	-4.13	-74.5487364621	5.54	10.02	1.41	1381412	2.57171262	CS
26	-6.4196	-81.9914171861	7.8296	10.02	1.41	722331	2.94248082	CS
52	-12.35	-89.7529069767	13.76	18.7192	1.41	402234	3.97503434	CS
156	-1107.39	-99.8728354978	1108.8	1649.4016	1.41	1945148	563.13768047	CS
260	-15324.67	-99.9907999958	15326.08	39916.8	1.41	2326316	2550.31003862	CS

SONN - Frequently Asked Questions (FAQ)

What is the current Sonnet BioTherapeutics share price?

The current share price of Sonnet BioTherapeutics is US$ 1.41

How many Sonnet BioTherapeutics shares are in issue?

Sonnet BioTherapeutics has 650,313 shares in issue

What is the market cap of Sonnet BioTherapeutics?

The market capitalisation of Sonnet BioTherapeutics is USD 1.01M

What is the 1 year trading range for Sonnet BioTherapeutics share price?

Sonnet BioTherapeutics has traded in the range of US$ 1.41 to US$ 18.7192 during the past year

What is the PE ratio of Sonnet BioTherapeutics?

The price to earnings ratio of Sonnet BioTherapeutics is -0.05

What is the cash to sales ratio of Sonnet BioTherapeutics?

The cash to sales ratio of Sonnet BioTherapeutics is 6.28

What is the reporting currency for Sonnet BioTherapeutics?

Sonnet BioTherapeutics reports financial results in USD

What is the latest annual turnover for Sonnet BioTherapeutics?

The latest annual turnover of Sonnet BioTherapeutics is USD 148k

What is the latest annual profit for Sonnet BioTherapeutics?

The latest annual profit of Sonnet BioTherapeutics is USD -18.83M

What is the registered address of Sonnet BioTherapeutics?

The registered address for Sonnet BioTherapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Sonnet BioTherapeutics website address?

The website address for Sonnet BioTherapeutics is www.sonnetbio.com

Which industry sector does Sonnet BioTherapeutics operate in?

Sonnet BioTherapeutics operates in the MANAGEMENT CONSULTING SVCS sector

Symbol	Price	Vol.
DRCTDirect Digital Holdings Inc	US$ 5.25 (854.55%)	68.44M
CHEKCheck Cap Ltd	US$ 2.24 (279.66%)	40M
SLGLSol Gel Technologies Ltd	US$ 1.57 (265.97%)	18.17M
RELIReliance Global Group Inc	US$ 3.08 (156.67%)	105.54M
TRAWTraws Pharma Inc	US$ 12.50 (149.00%)	28.22M
AILEiLearningEngines Inc	US$ 0.199 (-77.51%)	29.66M
MGOLMGO Global Inc	US$ 0.4765 (-49.84%)	14.13M
YHCLQR House Inc	US$ 1.11 (-36.57%)	1.28M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.4014 (-34.37%)	194.98M
ADGMAdagio Medical Holdings Inc	US$ 1.095 (-33.64%)	4.84M
EDBLEdible Garden AG Inc	US$ 0.3669 (54.35%)	407.91M
RGTIRigetti Computing Inc	US$ 10.945 (16.81%)	223.46M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.4014 (-34.37%)	191.91M
NVDANVIDIA Corporation	US$ 139.67 (3.69%)	174.6M
RIMEAlgorhythm Holdings Inc	US$ 0.0925 (21.07%)	155.68M

Symbol

Price

Vol.